Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
H&D Wireless Sweden Holding B | HDWB | Mar 27, 2024 | 0.03 | +13.33 |
H&M B | HMB | Mar 27, 2024 | 177.74 | +15.19 |
HAKI Safety A | HAKIA | Mar 27, 2024 | 25.20 | 0.00 |
HAKI Safety B | HAKIB | Mar 27, 2024 | 25.20 | 0.00 |
Hamlet BioPharma AB (publ) | HAMLETB | Mar 27, 2024 | 1.75 | +1.16 |
Hansa Biopharma | HNSA | Mar 27, 2024 | 29.36 | +1.24 |
Hanza AB | HANZA | Mar 27, 2024 | 65.40 | +1.08 |
Harm Reduction Group | NOHARM | Mar 27, 2024 | 0.16 | -0.61 |
Havsfrun Investment | HAVS | Mar 27, 2024 | 15.56 | +3.05 |
Havsfrun Investment B | HAVB | Mar 27, 2024 | 15.56 | +3.05 |
Haypp Group | HAYPP | Mar 27, 2024 | 83.00 | -1.19 |
Headsent | VIMAB | Mar 27, 2024 | 9.65 | -2.03 |
Heba B | HEBAB | Mar 27, 2024 | 34.25 | +0.74 |
Hedera Group | HEGR | Mar 27, 2024 | 5.82 | +3.56 |
Heimstaden Pref | HEIMPREF | Mar 27, 2024 | 8.75 | +8.02 |
Heliospectra | HELIO | Mar 27, 2024 | 0.36 | 0.00 |
Hemnet Group | HEM | Mar 27, 2024 | 329.80 | -1.90 |
Hemply Balance | HMPLY | Mar 27, 2024 | 0.04 | -4.26 |
Hexagon B | HEXAB | Mar 27, 2024 | 127.25 | -0.62 |
Hexagon Purus | HPURO | Mar 27, 2024 | 5.93 | 0.00 |
Hexatronic Group | HTRO | Mar 27, 2024 | 32.90 | +4.11 |
Hexicon | HEXI | Mar 27, 2024 | 0.50 | +3.23 |
Hexpol B | HPOLB | Mar 27, 2024 | 133.70 | +0.53 |
Hifab B | HIFAB | Mar 27, 2024 | 2.46 | +8.85 |
High Coast Distillery B | HIGHCOB | Mar 27, 2024 | 42.90 | -0.23 |
Hilbert | HILBB | Mar 27, 2024 | 4.11 | +0.49 |
HMS Networks | HMS | Mar 27, 2024 | 460.20 | -1.79 |
Hoegh Autoliners ASA | HAUTOO | Mar 27, 2024 | 92.80 | -0.22 |
Hoi Publishing AB | HOIB | Mar 27, 2024 | 0.41 | -2.38 |
Hoist Finance | HOFI | Mar 27, 2024 | 53.60 | +2.68 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.